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There are many studies on the prevalence, clinical characteristics, and economic burden of diabetes across the past four decades 
in Korea. Nonetheless, there is a dearth of nationwide study regarding diabetes encompassing all age group. Eight years ago, the 
Committee on the Epidemiology of Diabetes Mellitus of Korean Diabetes Association collaborated with Health Insurance Review 
& Assessment Service to evaluate the status of diabetes care and characteristics in diabetic patients in Korea. In 2007, the collab-
orative task force team published a comprehensive survey titled “Diabetes in Korea 2007.” In this review, we reappraise the dia-
betic epidemics from the joint report and suggest further studies that are needed to be investigated in the future.
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INTRODUCTION
Diabetes is an important chronic disease causing economic 
and social burden around the world [1]. The prevalence of type 
2 diabetes has substantially increased and is likely to continue 
to rise, particularly in developing areas including Asia [2].
 In Korea, numerous studies on the prevalence, clinical char-
acteristics and economic burden of diabetes has been performed 
across the past 40 years [3-7], which has recently extended to 
the evaluation of genomic features in diabetes. The prevalence 
of diabetes has increased 6- to 7-fold from 1.5% to 9.9%. Many 
well-designed population-based cohort studies, medical in-
surance data study, and reports on specific groups of patients, 
such as old age and gestational period, have been performed. 
Nonetheless, a nationwide study of diabetes including all age 
group is not yet common. Eight years ago, the Korean Diabe-
tes Association (KDA) organized a Committee working on the 
epidemiology of diabetes mellitus to construct nationwide 
data about diabetes and its managements in Korea. In 2006, 
the Committee formed a collaborative agreement with Health 
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Insurance Review & Assessment Service (HIRA), which is one 
of the several government agency collecting national health 
insurance data: since then, the name of the joint task force 
changed to Task Force Team for Basic Statistical Study of Ko-
rean Diabetes Mellitus (KDA-TFT for BSS) in 2006.
 The strategies of KDA-TFT for BSS were to evaluate current 
status of diabetes and its managements, to establish a standard 
care and quality standard, to demonstrate the effect of system-
atic management about diabetes, and to develop a standard 
model of chronic disease management. This joint report con-
sists of 1) the validity of health insurance data, 2) the preva-
lence, incidence, and clinical characteristics of diabetes, 3) 
complications and diabetes management, and 4) the health 
outcomes, use of healthcare service, and the cost of healthcare. 
We endeavored to obtain a comprehensive picture of diabetes 
from the national data on Korea [8-14].
VALIDITY OF HEALTH INSURANCE DATA
We constructed the profiles of diabetic patients (Fig. 1). First, 
we analyzed an approximately 250 million medical insurance 
claim database which has submitted at least once per year to 
HIRA with diabetes as a primary, secondary, or tertiary diag-
nostic codes in 2003 (ICD-10 code: E10 to E14). Diabetes was 
defined as those who have been prescribed diabetes medica-
tions between the year 2001 and 2003 or those who have ful-
filled the diabetes diagnostic criteria (fasting blood glucose 
≥126 or ≥200 mg/dL at a random or 2-hour postprandial blood 
glucose) on the medical record or those who were determined 
to be diabetic by physician. Using this database, we construct-
ed a patient-hospital profile encompassing 3,676,164 cases and 
then transformed it to a patient profile consisting of 2,412,082 
observations. The size of the total diabetic population was esti-
mated by weighting the sample survey results. Second, we ran-
domly selected 3,902 subjects out of 2,503,754 subjects with 
claims with diagnosis of diabetes between January 2003 and 
December 2003 by using a 2-staged cluster sampling method. 
Based on the evaluation of sampling design for estimating an 
epidemiologic volume of diabetes, we chose a target sample 
number of 4,000. Stratification was made into tertiary hospi-
tal:general hospital:hospital:clinic (5:10:10:75) and further 
into district, city, and county. It was identified that a two-stage 
cluster sampling with the first stage (random sampling of hos-
pitals within a strata) and the second stage (random sampling 
of patients in the selected hospital) was accurate and efficient. 
Detailed sampling method was described in previous study 
[11].
 A field survey with review of medical records and telephone 
survey was conducted with standardized record forms devel-
oped by KDA-TFT for BSS. Finally, 1,088,564 patients with di-
agnosis of diabetes or records of diabetes drug prescription in 
2002 aged 20 to 79 years old who survived until the end of year 
2004 were included (1st nationwide survey).
 The diagnosis validity was 87.2% (95% confidence interval 
[CI], 83.8% to 90.7%) for admission episodes and 72.3% (95% 
CI, 67.4% to 77.2%) for outpatient cases. In the analysis of the 
medical records of 3,902 patients sampled with the 2-stage 
cluster sampling from 2,412,082 patients for whom more than 
one claim was filed with diabetes, 62.7% (95% CI, 53.3% to 
71.2%) was identified as diabetic by the diabetes patient eligi-
bility criteria.
 The health insurance data from HIRA is considered slightly 
less accurate than other research data in terms of substantiality 
or reliability. However, this is the only data including the entire 
national population. Such large-size population makes it the 
best tool available in predicting public health trends.
PREVALENCE AND INCIDENCE
The prevalence of diabetes in the 2003 population was estimat-
ed to be 5.92% (n=2,860,402) of the total national population, 
with the proportion of 5.33% and 6.52% in men and women, 
respectively. The prevalence was 1.22 times higher in women. 
In the age group of 20 to 79 years, the prevalence was estimat-
ed at 7.7% (n=2,694,220). The present results are similar to 
other reports [5-7]. If the current trend in growth continues, 
the number of diabetic patients is likely to soar up to 3.51 mil-
2,503,754 Total number of subjects 
to claimed to HIRA with diabetes
2,412,082 Patient- 
hospital profile 
3,902 Stratified sampled 
diabetic patients
Stratified two-stage cluster sampling 
Whole national medical records 
sampled from HIRA in 2003
To evaluate the prevalence, incidence, 
complication, comorbidity, health outcome 
and medical cost (2003-2005)
To evaluate the clinical, biochemical 
characterization and diabetes management
with review over medical records and 
telephone survey in 2005
Fig. 1. Overview of the study. HIRA, Health Insurance Review 
& Assessment Service.
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lion by the year 2010 (7.08% of the estimated total population), 
4.55 million (8.97%) by 2020, and 5.45 million (10.85%) by 
2030 (Figs. 2, 3). According to the International Diabetes Fed-
eration report, Korea ranked 21st among the 30 Organisation 
for Economic Co-operation and Development (OECD) mem-
ber countries in terms of the adult (aged 20 to 79) diabetes prev-
alence. In our TFT results, diabetes prevalence in Korea is esti-
mated to be ranked between 11th and 12th. If the growth rate 
continues at the current rate, however, Korea may have the 
highest prevalence of diabetes among the OECD countries by 
the year 2030.
 The incidence of diabetes (in the 2003 population) was esti-
mated to be 0.57% (n=274,767) of the total population: 0.53% 
in men and 0.61% in women, respectively. The incidence was 
1.16 times higher in women. In the age group of 20 to 79 years, 
the estimated incidence was 0.76% (n=262,735): 0.73% in 
men and 0.78% in women, respectively. It is estimated that the 
diabetic population size would rapidly increase by 10% each 
year in the future.
CLINICAL CHARACTERISTICS OF DIABETIC 
PATIENTS
To evaluate the clinical characteristics of diabetic patients, we 
used the results from the 1st nationwide survey. Patterns and 
correlations of healthcare use for 2 years (year 2003 and 2004) 
and outcomes (hospitalization, death, and medical cost) for the 
following year (2005) were analyzed. Outpatient visit continu-
ance was defined as more than one visit per quarter (3 months) 
throughout the analysis period with diabetes as principal or 
secondary diagnosis. Income level was divided into five groups 
(20 percentile interval) by health insurance premium grades 
and actual premium amounts. Multivariate analysis was per-
formed with adjustment for gender, age, premium level, resi-
dential location, the first year of diagnosis, comorbidities, pre-
vious year hospitalization, main healthcare institution of use, 
prescription continuance, number of institutions visited for 
outpatient care, and outpatient visit continuance during the 
previous year.
 Our report shows that lower income level is associated with 
higher likelihood of hospitalization or death. They are also less 
likely to receive continuous outpatient care. The results show 
that a comprehensive healthcare service is necessary for low 
income patients. The 34.6% of the diabetic patients in this anal-
ysis had a family history (response rate, 62.7%). Body mass in-
dex (BMI) was used as a measurement of obesity. BMI <18.5 
kg/m2 was measured in 3.4% of subjects, 18.5 to 24.9 kg/m2 in 
57.2%, 25.0 to 29.9 kg/m2 in 34.2%, and ≥30 kg/m2 in 5.3%. 
Women had significantly higher BMI than men (24.7 kg/m2 
vs. 24.2 kg/m2, P<0.05). The results suggest that 39.5% of dia-
betics in Korea are obese (BMI≥25 kg/m2), which is still a low-
er proportion compared with Western countries. Current and 
past smokers accounted for 26.7% and 12.7%, respectively, com-
pared to 60.6% nonsmokers (response rate, 66.7%). Women 
had a higher percentage of nonsmokers compared with men 
(90.9% vs. 32.8%, P<0.001). The 41.3% of the diabetic patients 
consume one or more alcoholic beverages per month in this 
analysis. In men, this proportion was 61.5% as compared to 
19.5% in women, suggesting a higher rate of alcohol drinking 
in men (response rate, 66.0%).
Fig. 3. Diabetic population estimates factoring in age structure 
changes.
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COMPLICATIONS
To evaluate the foot disease, end-stage renal disease (ESRD) and 
ophthalmologic disease, we chose subjects different from the 
aforementioned data. Foot amputated patients were defined as 
those who made the first claim in 2003 with code Z894-899 as 
principal or secondary diagnosis or who had the first record of 
N0571-N0575 between October 2000 and December 2002 in 
the health insurance claims data. Foot ulcer patients were de-
fined as those who had the first record in 2003 with L97 (ulcer 
of lower limb) or R02 (gangrene) as principal or secondary di-
agnosis. ESRD prevalent patients were defined as those who 
had the record of chronic renal failure (N18 or N19) as princi-
pal or secondary diagnosis in their health insurance claims 
data between January 2001 and December 2003 and who re-
ceived renal replacement therapy with one of the following 
disease classification codes; dialysis (Z49), dependence on re-
nal dialysis (Z99.2), kidney transplant status (Z94.0), or with a 
specific disease code of V001 (hemodialysis), V003 (peritoneal 
dialysis), V005 (use of post kidney transplant immunosuppres-
sants), or R3280 (renal transplantation). Renal transplant pa-
tients were defined as those with claims of any of the following 
codes: Z94.0, V005, and R3280. New ESRD incident patients 
were defined as ESRD patients first diagnosed during 2003.
 The 44.8% of the foot amputated patients in 2003 were dia-
betic. Diabetic patients were 10.1 times more likely to undergo 
foot amputation (4.7 times after standardization for gender 
and age), and 7.8 times more likely to have foot ulcer (4.4 times 
after the standardization). Depending on hospitalization/non-
hospitalization, diabetic foot amputation was associated with 
1.6 or 2.1 times more annual days of healthcare use than non-
diabetic foot amputation. Diabetic foot ulcer was associated 
with 1.4 or 2.0 times more annual days of healthcare use. De-
pending on hospitalization/nonhospitalization, diabetic foot 
amputation was associated with 2.0 or 2.3 times higher total 
medical cost than nondiabetic foot amputation. Diabetic foot 
ulcer was associated with 1.7 or 3.2 times higher total medical 
cost. The results suggest that diabetes is a major underlying 
disease of foot diseases and that loss of human and/or finan-
cial resources to diabetic foot disease should not be underesti-
mated. 
 Diabetes affected 56.7% of the total prevalent ESRD patients 
(n=41,167) in Korea in 2003. ESRD was 20.8-fold more com-
mon in diabetic patients than non-diabetics (Fig. 4). Of those 
who newly began renal replacement therapy in 2003, 70.5% 
were diabetics. Diabetic patients were 1.6 times more likely to 
be hospitalized due to ESRD for a longer duration compared 
with nondiabetics. They were also likely to suffer 1.6 times 
higher hospitalization cost. Ophthalmologic disease including 
cataract (3.0 times), retinopathy (3.9 times), and glaucoma 
(1.5 times) was 1.9-fold more common in diabetic patients 
than nondiabetics. Acute stroke was estimated to be 5.2-fold 
more common in diabetic patients compared to general popu-
lation from the small case-control study (Fig. 4) [15]. The re-
sults suggest that compared to nondiabetics, complications 
among patients with diabetes are very common, becoming a 
heavier burden on the society and leading to a greater loss of 
human and/or financial resources.
DIABETES MANAGEMENT
We analyzed the 1st nationwide survey data to evaluate the 
current status of diabetes management. The medical record 
fill-out rate for family history, smoking history, and drinking 
history in diabetes patients was low at about 10%, with tertiary 
hospitals showing the highest rate of record keeping. Basic 
tests including BMI (18.0% measured over 6 months), blood 
pressure (56% over 6 months), lipid profile (46.3% over 1 year), 
and foot examination (6.1% over 2 years) in diabetes patients 
were being performed in a low portion of the patients. When 
classified by the type of health institutions, tertiary hospitals 
showed the highest test rate, followed by general hospitals, hos-
pitals, and clinics. Blood glucose was self-monitored in 34.9% 
of the subject patients. The 39.4% received education for dia-
betes management at least once while 60.6% never received 
Fig. 4. Relative risk of comorbidities and health outcome com-
pared with nondiabetics by simple comparison. 
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such education. Diabetes was treated with oral hypoglycemics 
alone in 70.0%, with insulin alone in 4.1%, with combination 
therapy of oral agents and insulin in 10.1%, and with diet/ex-
ercise in 15.8% of the patients (Fig. 5). Nonetheless, only 40.3% 
had their blood glucose controlled to glycated hemoglobin 
(HbA1c) <7%. These results on treatment methods or control 
rate were similar to the reports in the 2005 Korea National 
Health and Nutrition Examination Survey, where HbA1c <7% 
was observed in 43.5% of the subjects. The 63% of the adult 
diabetic patients aged 20 to 79 years received antihypertensive 
medications for more than 1 day a year. While 86.5% of the di-
abetic patients with comorbid hypertension were taking anti-
hypertensives, blood pressure of <140/90 mm Hg was achieved 
in 59% and <130/80 mm Hg in only 19%. Similarly, 70.2% of 
the diabetic patients with comorbid hyperlipidemia received 
lipid-lowering agents, but only 38% achieved low density lipo-
protein-cholesterol of <100 mg/dL (Fig. 6). Only 21.8% of the 
subject patients took medications for diabetes on a continuous 
basis (more than 360 days a year). Of the patients with newly 
diagnosed diabetes in 2003, 36.2%, and 13.2% were taking an-
tihypertensives and lipid-lowering agents, respectively. On the 
other hand, the percentage of the patients concomitantly taking 
aspirin was low at 11.6%, which lower than the proportion re-
ported in the United States. These results indicate that current 
diabetes treatment is not yet aggressive enough.
HEALTH OUTCOME
We reviewed the 1st nationwide survey data to evaluate the 
death outcome. The 1-, 2-, and 3-year mortality in the diabe-
tes-eligible patients was estimated to be 3.95%, 5.89%, and 
8.52%, respectively. In the incident diabetes patients (new pa-
tients), the same year mortality was 1.5 to 2 times higher at 
7.56%, 9.70%, and 13.11%, respectively. Overall, the mortality 
due to diabetes was higher in men than women, in newly di-
agnosed patients than in established patients, and in the age 
group of 45 to 54 years than the age group of 55 to 64 years. 
When standard mortality ratio was generated for comparison 
with the general population, the ratio of diabetes-eligible pa-
tients was 3.1, 2.4, and 2.2 at 1, 2, and 3 years, respectively, 
showing that the gap between the two populations decreased 
over time. The mortality ratio of the incident diabetes patients 
was 7.3, 4.9, and 4.2 at 1, 2, and 3 years, respectively, also show-
ing decreasing trend over time. These results suggest that mor-
tality in diabetes patients is 3.1-fold higher than in the general 
population. The newly diagnosed patients, in particular, shows 
7.3-fold higher mortality (adjusted for gender and age differ-
ence) (Fig. 4).
USE OF HEALTHCARE SERVICE AND THE 
COST
The total number of diabetes patients in 2003 was estimated at 
2.86 million. Among them, only 52.9% used healthcare service 
for diabetes at least once a year (48.0% in women, 58.8% in 
men).
 The annual rate of hospitalization in diabetes patients was 
10.3%, with an average of 22.4 hospitalization day per year. 
Patients who received outpatient care made an average of 12.2 
visits to health institutions per year. The total medical cost in 
the adult diabetes patients (aged 20 to 79 years) was 3,185 bil-
lion KRW, accounting for about one-fifth (19.2%) of the total 
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Fig. 5. Blood glucose control methods in the diabetes-eligible 
patients.
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cost in the entire adult population. The total medical cost per 
person in the diabetes patients was 4.6 times higher than the 
general population. The gap narrowed to a 3-fold difference 
after adjusting for gender and age. The number of patients who 
filed insurance claims for diabetes increased by 2.9-fold across 
a decade, from 800,000 (1.8% of the entire population) in 1995 
to 2.33 million (4.8%) in 2005. During the same period, the 
total medical cost in the patients with diabetes (as principal or 
secondary diagnosis) increased by as much as 7.99-fold, from 
214 billion KRW in 1995 to 1,712 billion KRW in 2005. This 
large increase was attributable to the increase in the per-capita 
healthcare service utilization rate to treat diabetes (responsible 
for 2.09-fold or 35.5% of the increase), population aging (1.40-
fold or 16.1%) the increase in healthcare service price index 
(1.85-fold or 29.7%), and net cost growth after adjustment for 
the price index (1.48-fold or 18.7%).
 These results suggest that the economic burden of diabetes 
and its management is serious. 
CONCLUSIONS
The limitation of this report lies in the inaccuracy of ICD-10 
diagnosis code of diabetes. Therefore, the validity of health in-
surance data is relatively low compared to other well-designed 
controlled studies. However, we performed face to face field 
study and telephone survey to randomized samples to overcome 
the limitation. Despite the slightly low validity, this is the only 
data to encompass the entire national population. The large 
size population makes it the best available tool available in 
foreseeing public health trends.
 The prevalence and incidence of diabetes in Korea are pre-
dicted to increase until up to year 2030, and the national eco-
nomic burden subsequently become heavier in the future. A 
comprehensive effort aiming to decrease the economic burden 
and comorbidities of diabetes is necessary.
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